p53 mutations in human cancers; Participation of p53 protein in the cellular response to DNA damage; A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination …; Evidence for a causal association between human papillomavirus and a subset of head and neck cancers; World Health Organization classification of tumours: pathology and genetics of head and neck tumours; Pathology and genetics of head and neck tumours; 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers; Inactivation of the CDKN2/p16/MTS1 Gene Is Frequently Associated with Aberrant DNA Methylation in All Common Human Cancers; Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1; Genetic progression model for head and neck cancer: implications for field cancerization; Head and neck cancer; Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients; BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer; Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer; BRAF mutation in papillary thyroid carcinoma; Identification of p53 gene mutations in bladder cancers and urine samples; Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma; Facile detection of mitochondrial DNA mutations in tumors and bodily fluids; Frequent Inactivation of PTEN/MMAC1 in Primary Prostate Cancer; Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors
